Agoracom Blog Home

Posts Tagged ‘fake news’

Datametrex $DM.ca Announces #COVID19 Test Kits Purchase Orders From a Canadian Health and Safety Company

Posted by AGORACOM-JC at 2:38 PM on Wednesday, June 10th, 2020
  • Received purchase orders for COVID-19 test kits from a Canadian Health and Safety Company
  • PO is comprising of 2,000 1 Drop Inc.’s Nucleic Acid test kits, 2,000 Universal Transport Medium (UTM®) Sterile Swabs with 16x100mm Skirted Tubes, 4 Real-Time PCR Detection System machines to analyze the samples, and 1 RNA extractor
  • The total value of the PO is approximately $360,000 CDN.

TORONTO, June 10, 2020 – Datametrex AI Limited (the “Company” or “Datametrex“) (TSXV: DM, FSE: D4G, OTC: DTMXF) is pleased to announce that it has received purchase orders (the “PO”) for COVID-19 test kits from a Canadian Health and Safety Company.

The PO is comprising of 2,000 1 Drop Inc.’s Nucleic Acid test kits, 2,000 Universal Transport Medium (UTM®) Sterile Swabs with 16x100mm Skirted Tubes, 4 Real-Time PCR Detection System machines to analyze the samples, and 1 RNA extractor.

Datametrex is ready to supply a strong demand in the North American market for clinically supported COVID-19 test kits. The total value of the PO is approximately $360,000 CDN.

Datametrex anticipates that it will have little or no upfront costs associated with the sale of these test kits. The Company has secured all testing kits, swabs, tubes and the PCR machine from the manufacturer required to fulfill the order. All the items will be shipped directly from manufacturers to the purchasers at their operating site in British Columbia.

“According to Coherent Market Insights, the global COVID-19 detection kits market is estimated to be valued at US$ 3.30 billion in 2020. We are working diligently to support global efforts in reducing the spread of the virus. These tests are vital for management to help protect employees as they provide accurate diagnoses and enable the prevention of the spread of the infection,” says Marshall Gunter, CEO of the Company.

Datametrex’s mission is to provide tools that support companies in fulfilling their operational Health and Safety goals with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, the Company provides progressive solutions to support the supply chain.

About Datametrex

Datametrex AI Limited is a technology focused company with exposure to Artificial Intelligence and Machine Learning through its wholly owned subsidiary, Nexalogy (www.nexalogy.com). Datametrex’s mission is to provide tools that support companies in fulfilling their operational goals, including Health and Safety, with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, the Company provides progressive solutions to support the supply chain. Additional information on Datametrex is available at www.datametrex.com

For further information, please contact:

Marshall Gunter – CEO
Phone: (514) 295-2300
Email: [email protected] 

Neither the TSX Venture Exchange nor it’s Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may,” “will,” “expect,” “likely,” “should,” “would,” “plan,” “anticipate,” “intend,” “potential,” “proposed,” “estimate,” “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.

Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

Datametrex $DM.ca Hires Former #LOTTE Executive to Sales Team

Posted by AGORACOM-JC at 9:33 AM on Wednesday, June 10th, 2020
  • Former executive from LOTTE Data Communication Ltd., Edward Choi, joined the Company to head up the sales team in Seoul, South Korea
  • Edward was a Vice President at LOTTE for leading Lotte’s cyber security division

TORONTO, June 10, 2020 – Datametrex AI Limited (the “Company” or “Datametrex“) (TSXV: DM, FSE: D4G, OTC: DTMXF) is pleased to announce that former executive from LOTTE Data Communication Ltd. (“LOTTE”), Edward Choi, joined the Company to head up the sales team in Seoul, South Korea. Edward was a Vice President at LOTTE for leading Lotte’s cyber security division.

“Adding Edward to the sales team in a leadership capacity is a strategic move for Datametrex. His contacts at LOTTE will allow Datametrex to open more doors and build on the strong foundation we’ve established these past three years,” says Marshall Gunter, CEO of the Company.

About Datametrex AI Limited

Datametrex AI Limited is a technology focused company with exposure to Artificial Intelligence and Machine Learning through its wholly owned subsidiary, Nexalogy (www.nexalogy.com). Datametrex’s mission is to provide tools that support companies in fulfilling their operational goals, including Health and Safety, with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, the Company provides progressive solutions to support the supply chain. Additional information on Datametrex is available at www.datametrex.com.

For further information, please contact:

Marshall Gunter – CEO
Phone: (514) 295-2300
Email: [email protected]

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.

Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

Datametrex $DM.ca Announces Sale of COVID-19 Test Kits to Canadian Royalties

Posted by AGORACOM-JC at 1:36 PM on Tuesday, June 9th, 2020
  • Received a purchase order for COVID-19 test kits from Canadian Royalties Inc. a Quebec based mining company
  • Under the terms of the PO, Datametrex will sell to the purchaser an intial 2,000 units of Health Canada authorized COVID-19 qPCR Detection Kits
  • Datametrex anticipates that it will have little or no upfront costs associated with the sale of these test kits

TORONTO, June 09, 2020 – Datametrex AI Limited (the “Company” or “Datametrex”) (TSXV: DM, FSE: D4G, OTC: DTMXF) is pleased to announce that it has received a purchase order (the “PO”) for COVID-19 test kits from Canadian Royalties Inc. (“CRI”), a Quebec based mining company.

Under the terms of the PO, Datametrex will sell to the purchaser an intial 2,000 units of Health Canada authorized COVID-19 qPCR Detection Kits manufactured by 1drop Inc. and 2,000 3 mL Univesal Transport Medium (UTM®) Sterile Swabs with 16x100mm Skirted Tubes with testing being conducted by Transpharm Canada Inc. (“TCI”). The Company has secured all testing kits from the manufacturer required to fulfill the order. All of the items will be shipped directly from manufacturer to the TCI lab. Datametrex anticipates that it will have little or no upfront costs associated with the sale of these test kits.

“It has been a pleasure working with the team at Canadian Royalties, their commitment to keeping their operations open in a responsible and safe manner is truly representative of the Canadian spirit we are proud to be part of,” said Marshall Gunter, CEO of the Company.

Datametrex’s mission is to provide tools that support companies in fulfilling their operational Health and Safety goals with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, the Company provides progressive solutions to support the supply chain.

About Canadian Royalties

Canadian Royalties Inc. (“CRI”) is a private mining company based in Montreal that operates a copper and nickel mine in Nunavik (province of Quebec), under the name Nunavik Nickel Project (“Project”). The production phase started in February 2013, with a concentrator of a capacity of 4,500 tons/day, fed by various mines, including EXPO, ALLAMMAQ and MEQUILLON. CRI’s nickel and copper concentrates are trucked and stored daily at our Deception Bay port facilities, about 120 km from the main EXPO camp.  An ice-breaker vessel named “Nunavik”, comes to Deception roughly seven times a year, bringing operational material from overseas and pick up concentrate to deliver to Europe. CRI allows more than 1,000 people to work on its facilities for the operations, including 600 direct employees and 400 subcontractors. It is an average of 400 people who live and work on constant rotation on the Project, whether at EXPO camp or Deception Bay camp, all on a fly-in / fly-out rotation. We also have about thirty employees based at our Montreal corporate offices. Additional information on CRI is available at www.canadianroyalties.com

About Transpharm Canada Inc.

Transpharm Canada Inc. provides pharmaceutical education, technology, and research opportunities to students through its subsidiary, Toronto Institute of Pharmaceutical Technology, North America’s premier pharmaceutical training institute. The facility is also fully compliant Health Canada licensed Good Manufacturing Practice (“GMP”) manufacturing and testing facility and is a full-service clinical development business that provides clinical trial services to biotechnology companies.  Additional information on TIPT is available at www.tipt.com

About 1drop Inc.

1drop Inc. aims to provide a solution to manage health with a drop of fluid. It has the key technologies for becoming a global leading company in the field of smart health care. 1copy™ COVID-19 qPCR Multi Kit can reduce the risk of asymptomatic and latent infection of COVID-19 by a single virus level limit of detection. Additional information on 1drop Inc. is available at www.1drop.co.kr

About Datametrex

Datametrex AI Limited is a technology focused company with exposure to Artificial Intelligence and Machine Learning through its wholly owned subsidiary, Nexalogy (www.nexalogy.com). Datametrex’s mission is to provide tools that support companies in fulfilling their operational goals, including Health and Safety, with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, the Company provides progressive solutions to support the supply chain. Additional information on Datametrex is available at www.datametrex.com. 

For further information, please contact:

Marshall Gunter – CEO
Phone: (514) 295-2300
Email: [email protected]

Neither the TSX Venture Exchange nor it’s Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws.  All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

Two #COVID19 Test Kits Distributed by #Datametrex $DM.ca Granted FDA Emergency Use Authorization

Posted by AGORACOM-JC at 7:09 AM on Tuesday, June 9th, 2020
  • Announced that Seasun Biomaterial’s 20 minute rapid Nucleic Acid test kit, AQ-TOP COVID-19 Rapid Detection Kit, has received authorization from the U.S. Food & Drug Administration
  • Registered under the Coronavirus Disease 2019 (COVID-19) Emergency Use Authorizations for Medical Devices
  • So far, Datametrex has a total of three test kits that are FDA approved under Coronavirus Disease 2019 (COVID-19) Emergency Use Authorizations for Medical Devices available for sale

TORONTO, June 09, 2020 — Datametrex AI Limited (the “Company” or “Datametrex“) (TSXV: DM, FSE: D4G, OTC: DTMXF) is pleased to announce that Seasun Biomaterial’s 20 minute rapid Nucleic Acid test kit, AQ-TOP COVID-19 Rapid Detection Kit, has received authorization from the U.S. Food & Drug Administration (“FDA”) registered under the Coronavirus Disease 2019 (COVID-19) Emergency Use Authorizations for Medical Devices (“EUA”).

“These test kits can expedite the process of testing by reducing testing times, aiding in an earlier detection of the virus, a more accurate prediction of the positive cases, and a decrease of the infection rate,” said Marshall Gunter, CEO of the Company.

Additionally Datametrex would like to provide an update on the 1drop Inc. (“1drop”) test kits. The 1copy™ COVID-19 qPCR Multi Kit has secured FDA authorization under the EUA. This is a nucleic test kit providing results in less than two hours that verifies the RdRp gene for SARS-CoV-2 with real-time qPCR kits via a nasopharyngeal swab and oropharyngeal swab, specifically targeting the E gene sequences of COVID-19.

So far, Datametrex has a total of three (3) test kits that are FDA approved under Coronavirus Disease 2019 (COVID-19) Emergency Use Authorizations for Medical Devices (“EUA”) available for sale. The approved test kits are 1copy™ COVID-19 qPCR Multi kit, Seasun U-TOP™ COVID 19 Detection Kit, and AQ-TOP COVID-19 Rapid Detection Kit.

“Having seen the urgent need for COVID-19 test kits, Datametrex is doing everything it can to help Canada combat COVID-19 and flatten the curve. In the meantime, having FDA under EUA approved test kits allow us to help our neighbours to the south and any Canadian company with operations in the US,” says Marshall Gunter, CEO of the Company.

With regard to the FDA authorization: (1) this test has not been FDA cleared or approved; (2) this test has been authorized by the FDA only for the detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens; and (3) this test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.

The Company’s ability to fulfill any purchase order for COVID-19 test kits is subject to the availability of inventory at the time of order. Due to the extraordinarily high demand for COVID-19 test, there is volatility in the supply chain and available supply may fluctuate on a daily basis. Datametrex anticipates that it will have little or no upfront costs associated with importing and selling these test kits.

About Seasun Biomaterials

Seasun Biomaterials Inc. (“Seasun”) of South Korea is an in vitro diagnostic company that develops molecular diagnostic platforms of infection diseases, cancer as well as genetic and epigenetic disorders. Developing and commercializing innovative real-time PCR-based diagnostic platforms through the development of our proprietary technologies to provide more advanced molecular diagnostic services. Additional information on Seasun is available at www.seasunbio.com

About 1drop Inc.

1drop Inc. aims to provide a solution to manage health with a drop of fluid. It has the key technologies for becoming a global leading company in the field of smart health care. 1copy™ COVID-19 qPCR Multi Kit can reduce the risk of asymptomatic and latent infection of COVID-19 by a single virus level limit of detection. It is located in South Korea and is a medical technology spin-off from Samsung Electronic’s C-Lab program. The C-Lab is an internal incubation program within Samsung that first started in 2012 to help inspire a more creative company culture. 1drop already has more than five products approved in Europe in the past 18 months under the CE marking certification. The team has been working around the clock to identify and source high quality test kits from South Korea for Canada. Additional information on 1drop Inc. is available at www.1drop.co.kr

About Food and Drug Administration EUA

On February 4, 2020, pursuant to Section 564(b)(1)(C) of the Act, the Secretary of the Department of Health and Human Services (HHS) determined that there is a public health emergency that has a significant potential to affect national security or the health and security of United States citizens living abroad, and that involves the virus that causes COVID-19. Pursuant to Section 564 of the Act, and on the basis of such determination, the Secretary of HHS then declared that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of the virus that causes COVID-19 subject to the terms of any authorization issued under Section 564(a) of the Act.

About Datametrex

Datametrex AI Limited is a technology focused company with exposure to Artificial Intelligence and Machine Learning through its wholly owned subsidiary, Nexalogy (www.nexalogy.com). Datametrex’s mission is to provide tools that support companies in fulfilling their operational goals, including Health and Safety, with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, the Company provides progressive solutions to support the supply chain. Additional information on Datametrex is available at www.datametrex.com.

For further information, please contact:
Marshall Gunter – CEO
Phone: (514) 295-2300
Email: [email protected]

Neither the TSX Venture Exchange nor it’s Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.

Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

Datametrex $DM.ca Announces Another Sale of COVID-19 Test Kits to a Canadian Mining Company

Posted by AGORACOM-JC at 9:42 AM on Monday, June 8th, 2020
  • Announced a purchase order of COVID-19 test kits from a Canadian based mining company with thousands of employees in multiple jurisdictions
  • This PO is for their Ontario and Quebec operations
  • Total gross sales amount is approximately $450,000 CDN, excluding shipping and courier fees

TORONTO, June 08, 2020 — Datametrex AI Limited (the “Company” or “Datametrex”) (TSXV: DM, FSE: D4G, OTC: DTMXF) is pleased to announce a purchase order (the “PO”) of COVID-19 test kits from a Canadian based mining company (the “Purchaser”) with thousands of employees in multiple jurisdictions. This PO is for their Ontario and Quebec operations.

Under the PO, Datametrex will provide the Purchaser with 10,000 units of the COVID-19 qPCR Detection Kits manufactured by 1drop Inc., 10,000 3 mL Universal Transport Medium (UTM®) Sterile Swabs with 16x100mm Skirted Tubes, and 2 Real-Time PCR Detection System machine to analyze the samples.

The total gross sales amount is approximately $450,000 CDN, excluding shipping and courier fees. The Company has secured all requested testing kits, swabs, tubes, and the PCR machines. All of the items will be imported and distributed to the mining company at their operating sites in Ontario and Quebec. Datametrex anticipates that it will have little or no upfront costs associated with the sale of these test kits.

Ontario and Quebec account for more than 90% of Canadian COVID-19 cases and until there is a vaccine the mining community must carefully balance the risks with the unintended social and health consequences associated with spread of COVID-19 with getting miners back to work. Datametrex feels that a frequent testing, tracking and contact tracing strategy to further monitor and contain the spread of the virus is vital for companies to get employees working and for the reopening of economies. The direct cost to companies using the COVID-19 test kits in the Companies portfolio are a small cost to pay to open operations.

Since March, the World Health Organization (the “WHO”) has urged countries to scale up the testing, isolation and contact tracing of COVID-19 patients in order to fight the pandemic. As the pandemic progressed, some countries, including South Korea, were able to use testing and tracing to control the disease and avert lockdown measures and closure of industries. “Datametrex is honoured to be assisting Canadian companies in the health and welfare of their employees. We are proud to be able to help Canadians and companies to reopen businesses around the world and to help people return to work safely. We sincerely wish them and all Canadian companies the best during this pandemic,” says Marshall Gunter, CEO of the Company.

About Datametrex

Datametrex AI Limited is a technology focused company with exposure to Artificial Intelligence and Machine Learning through its wholly owned subsidiary, Nexalogy (www.nexalogy.com). Datametrex’s mission is to provide tools that support companies in fulfilling their operational goals, including Health and Safety, with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, the Company provides progressive solutions to support the supply chain. Additional information on Datametrex is available at www.datametrex.com.

For further information, please contact:

Marshall Gunter – CEO
Phone: (514) 295-2300
Email: [email protected]

Neither the TSX Venture Exchange nor it’s Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws.  All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.

Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

Social media firms fail to act on #Covid19 fake news – SPONSOR: Datametrex AI Limited $DM.ca

Posted by AGORACOM-JC at 1:15 PM on Friday, June 5th, 2020

SPONSOR: Datametrex AI Limited (TSX-V: DM) A revenue generating small cap A.I. company that NATO and Canadian Defence are using to fight fake news & social media threats. The company is working with US Government agencies on Covid19 and Coronavirus fake news and disinformation. The company also obtained the rights to import and sell COVID-19 test kits from South Korea – Click here for more info.

Social media firms fail to act on Covid-19 fake news

  • Hundreds of posts spreading misinformation about Covid-19 are being left online, according to a report from the Center for Countering Digital Hate.
  • Some 649 posts were reported to Facebook and Twitter, including false cures, anti-vaccination propaganda and conspiracy theories around 5G.

90% remained visible online afterwards without any warnings attached, the report suggests.

Facebook said the sample was “not representative”.

A spokesperson for Facebook said; “We are taking aggressive steps to remove harmful misinformation from our platforms and have removed hundreds of thousands of these posts, including claims about false cures.

“During March and April we placed warning labels on around 90 million pieces of content related to Covid-19 and these labels stopped people viewing the original content 95% of the time.

“We will notify anyone who has liked, shared or commented on posts related to Covid-19 that we’ve since removed.”

Twitter said that it was prioritising the removal of Covid-19 content “when it has a call to action that could potentially cause harm”.

“As we’ve said previously, we will not take enforcement action on every Tweet that contains incomplete or disputed information about Covid-19. Since introducing these new policies on March 18 and as we’ve doubled down on tech, our automated systems have challenged more than 4.3 million accounts which were targeting discussions around Covid-19 with spammy or manipulative behaviours.”

Imran Ahmed, chief executive of the Center for Countering Digital Hate, said the firms were “shirking their responsibilities”.

“Their systems for reporting misinformation and dealing with it are simply not fit for purpose.

“Social media giants have claimed many times that they are taking Covid-related misinformation seriously, but this new research shows that even when they are handed the posts promoting misinformation, they fail to take action.”

Rosanne Palmer-White, director of youth action group Restless Development, which also took part in the survey, said young people were “doing their bit to stop the spread of misinformation” but social media firms were “letting them down”.

Both Twitter and Facebook face questions from the UK’s Digital Culture Media and Sport sub-committee on the way they are handling coronavirus misinformation.

MPs were not happy with an earlier session. They demanded more detailed answers and said more senior executives should attend the next meeting.

For the study, ten volunteers from the UK, Ireland and Romania searched social media for misinformation from the end of April to the end of May.

They found posts suggesting sufferers can get rid of coronavirus by drinking aspirin dissolved in hot water or by taking zinc and vitamin C and D supplements,

Twitter was deemed the least responsive, with only 3% of the 179 posts acted upon.

Facebook removed 10% of the 334 posts reported and flagged another 2% as false. Instagram, which Facebook owns, acted on 10% of the 135 complaints it was sent.

Both the social networks insist they have made efforts to bring fake news about the coronavirus under control.

Twitter has begun labelling tweets that spread misinformation about Covid-19. Facebook has also removed some content, including from groups claiming the rollout of the 5G network was a cause of the spread of the virus.

Source: https://www.bbc.com/news/technology-52903680

Datametrex $DM.ca Awarded Tender for COVID-19 Test Kits From Canadian Mining Company

Posted by AGORACOM-JC at 8:19 AM on Friday, June 5th, 2020
  • Awarded a tender for COVID-19 test kits from a Quebec based mining company; the Supply Arrangement
  • Under the SA, the mining company will order an initial 2,000 units of Health Canada authorized COVID-19 qPCR Detection Kits manufactured by 1drop Inc. with testing being conducted by Transpharm Canada Inc.
  • Datametrex anticipates that it will have little or no upfront costs associated with the sale of these test kits

TORONTO, June 05, 2020 — Datametrex AI Limited (the “Company” or “Datametrex”) (TSXV: DM, FSE: D4G, OTC: DTMXF) is pleased to announce that it has been awarded a tender for COVID-19 test kits from a Quebec based mining company; the Supply Arrangement (the “SA”).

Under the SA, the mining company will order an initial 2,000 units of Health Canada authorized COVID-19 qPCR Detection Kits manufactured by 1drop Inc. with testing being conducted by Transpharm Canada Inc. (“TCI”). The Company has secured all testing kits from the manufacturer required to fulfill the order. All of the items will be shipped directly from manufacturer to the TCI lab. Datametrex anticipates that it will have little or no upfront costs associated with the sale of these test kits.

“By offering security technologies, Datametrex reaffirms its commitment to its customers, shareholders, families, and the Canadian public. We sincerely hope to aid in the reopening of businesses and social and cultural events in a safe and economic way,” said Marshall Gunter, CEO of Datametrex.

Infectious disease experts have indicated that without continuous testing there is a higher possibility of a second outbreak. According to Canada’s chief public health officer, Dr. Theresa Tam, reopening schools and businesses relies on testing and the ability of public health departments to trace the contacts of positive cases.

Datametrex’s mission is to provide tools that support companies in fulfilling their operational goals, including Health and Safety with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, the Company provides progressive solutions to support the supply chain.

About Transpharm Canada Inc.

Transpharm Canada Inc. provides pharmaceutical education, technology, and research opportunities to students through its subsidiary, Toronto Institute of Pharmaceutical Technology, North America’s premier pharmaceutical training institute. The facility is also fully compliant Health Canada licensed Good Manufacturing Practice (“GMP”) manufacturing and testing facility and is a full-service clinical development business that provides clinical trial services to biotechnology companies.  Additional information on TIPT is available at www.tipt.com.

About 1drop Inc.

1drop Inc. aims to provide a solution to manage health with a drop of fluid. It has the key technologies for becoming a global leading company in the field of smart health care. 1copy™ COVID-19 qPCR Multi Kit can reduce the risk of asymptomatic and latent infection of COVID-19 by a single virus level limit of detection. Additional information on 1drop Inc. is available at www.1drop.co.kr.

About Datametrex

Datametrex AI Limited is a technology focused company with exposure to Artificial Intelligence and Machine Learning through its wholly owned subsidiary, Nexalogy (www.nexalogy.com).

Additional information on Datametrex is available at www.datametrex.com.

For further information, please contact:

Marshall Gunter – CEO
Phone: (514) 295-2300
Email: [email protected]

Neither the TSX Venture Exchange nor it’s Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws.  All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.

Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

Five Tell-Tale Signs Of A Fake News Story – SPONSOR: Datametrex AI Limited $DM.ca

Posted by AGORACOM-JC at 5:42 PM on Thursday, June 4th, 2020

SPONSOR: Datametrex AI Limited (TSX-V: DM) A revenue generating small cap A.I. company that NATO and Canadian Defence are using to fight fake news & social media threats. The company is working with US Government agencies on Covid19 and Coronavirus fake news and disinformation. The company also obtained the rights to import and sell COVID-19 test kits from South Korea – Click here for more info.

Five Tell-Tale Signs Of A Fake News Story

  • As you know, there has been a lot of talk about fake news stories lately, and tech companies, like Facebook and Google, have been looking for ways to incorporate fact-checking into their operations
  • These attempts to keep misinformation at bay will no doubt be helpful, but in the end, much of the responsibility lies with the readers themselves

By: Bernadette Coleman

The other day, I shared a news story I had received in my inbox with my husband. After reading him the email, he gave me a glance, slowly put the “loser” finger sign to his forehead in jest and simply said, “fake news.” Was it? At first glance, I didn’t think it was, so I looked again.

As you know, there has been a lot of talk about fake news stories lately, and tech companies, like Facebook and Google, have been looking for ways to incorporate fact-checking into their operations. These attempts to keep misinformation at bay will no doubt be helpful, but in the end, much of the responsibility lies with the readers themselves. I decided to not fall for fake news again.

It was at that moment of clarity that I really started looking. Now, if I encounter a news story that seems rather odd or hard to believe, I thoroughly vet that information as well as I can before passing it on to my husband and friends or discussing it with my colleagues at work. As I recently found out, falling for a fake news story can leave you feeling gullible, and passing on that false information could have far-reaching implications for the wider population. At least it will have your significant other looking at you oddly.

I figured the best defense against being suckered in by all the misinformation on the internet is to be well-read and well-informed on topics that interest me. The more I know about the world around me, the easier it will be for me to spot the tell-tale signs of a fake news story.

So here are some signs that the story you and I are reading may be less than truthful.

1. Unusual Or Unknown Web Addresses

Whether you are browsing through your Facebook feed, checking out your favorite news aggregator or reviewing the results of your latest search query, pay careful attention to the source of the story. You should be checking out the URL associated with the news story.

An unusual or unknown web address is a big red flag and a sign that you are dealing with a fake news source. Watch out for URLs that look similar to real news sources. Sites like msnbc.com.com or nytimes.biz may appear legitimate at first glance, but the unusual web address is a dead giveaway.

2. A Lack Of Corroboration

If a major political party candidate has been indicted on the eve of an election, you would expect to find those news headlines everywhere. If all you can find is a single headline in your Facebook newsfeed, you can be fairly certain the story is fake.

Whenever you spot an unusual story or piece of late-breaking news, you should first look for corroboration elsewhere. If the story is legitimate, it will show up on mainstream news sites that you recognize. If the story is a fake, it will probably be confined to more questionable sites, and that lack of corroboration should lead you to do further research.

3. An Old Date On A ‘Breaking’ News Story

One common trick of fake news publishers is presenting an outdated or previously debunked story as breaking news. When users click on a banner headline in search of breaking news, they often find an old story presented as if it were brand new.

Get into the habit of checking the dates on stories you read and links you click. If the date is an old one, you can be sure you are not dealing with new information.

You can go further and check to see if the story has been debunked since its original publication. Myth-busting sites like Snopes.com can be great for this kind of thing.

4. An Obvious Slant Or Bias By The Authors

One of the hallmarks of professional journalists is their independence, so an obvious slant or bias by the author can be a red flag. Even jaded readers who feel the mainstream media carries an inherent bias should be suspicious of stories that appear to support one side over the other in an obvious way, so always ask yourself what the writer has to gain.

A certain degree of bias is to be expected in an opinion piece or editorial. However, if the story is presented as straight reporting or journalism, an obvious slant might be an indication that the entire piece is fake.

5. A Sensational Headline

News writers work hard to get the attention of their readers. That is what headline writing is all about. That same dynamic holds true on the internet, where the competition for eyeballs is even more intense. Even so, if a headline seems like clickbait, it probably is.

A sensational headline is one of the tell-tale signs of a fake news story, and you should proceed with caution when you see one. If the headline would be more at home on a supermarket tabloid than in a real newspaper, the associated story could be fake.

Despite the efforts of Facebook, Google and other online giants, fake news stories are unlikely to disappear any time soon. With so many sites competing for viewers and so much money to be made, fake news publishers will probably be around for quite some time. The best way to protect yourself is to be an educated reader. The more you know, the easier it will be to tell the fake news stories from their legitimate counterparts.

I believe we need to cultivate an awareness of what’s fake and what’s not fake on the internet. Helping people understand that when they share fake news, they are littering our space is a must. We can only do this if we do this together!

Source: https://www.forbes.com/sites/forbesagencycouncil/2020/06/04/five-tell-tale-signs-of-a-fake-news-story/#619fd7ad7d79

#AI tools could improve fake news detection by analyzing users’ interactions and comments – SPONSOR: Datametrex AI Limited $DM.ca

Posted by AGORACOM-JC at 5:12 PM on Tuesday, June 2nd, 2020

SPONSOR: Datametrex AI Limited (TSX-V: DM) A revenue generating small cap A.I. company that NATO and Canadian Defence are using to fight fake news & social media threats. The company is working with US Government agencies on Covid19 and Coronavirus fake news and disinformation. The company also obtained the rights to import and sell COVID-19 test kits from South Korea – Click here for more info.

AI tools could improve fake news detection by analyzing users’ interactions and comments

  • According to the Pew Research Center, approximately 68% of U.S. adults got their news from social media in 2018 — which is worrisome, considering misinformation about the pandemic, for instance, continues to go viral
  • Companies from Facebook and Twitter to Google are pursuing automated detection solutions, but fake news remains a moving target, owing to its topical and stylistic diversity

By: Kyle Wiggers

In a paper published on the preprint server Arxiv.org, researchers affiliated with Microsoft and Arizona State University propose an approach to detecting fake news that leverages a technique called weak social supervision. They say that by enabling the training of fake news-detecting AI even in scenarios where labeled examples aren’t available, weak social supervision opens the door to exploring how aspects of user interactions indicate that news might be misleading.

According to the Pew Research Center, approximately 68% of U.S. adults got their news from social media in 2018 — which is worrisome, considering misinformation about the pandemic, for instance, continues to go viral. Companies from Facebook and Twitter to Google are pursuing automated detection solutions, but fake news remains a moving target, owing to its topical and stylistic diversity.

Building on a study published in April, the coauthors of this latest work suggest that weak supervision — where noisy or imprecise sources provide data labeling signals — could improve fake news detection accuracy without requiring fine-tuning. To this end, they built a framework dubbed Tri-relationship for Fake News (TiFN) that models social media users and their connections as an “interaction network” to detect fake news.

Interaction networks describe the relationships between entities like publishers, news stories, and users. Given an interaction network, TiFN aims to embed different types of entities, based on the observation that people tend to interact with like-minded friends. In making its predictions, the framework also accounts for the fact that connected users are more likely to share similar interests in news pieces, that publishers with a high degree of political bias are more likely to publish fake news, and that users with low credibility are more likely to spread fake news.VB Transform 2020 Online – July 15-17. Join leading AI executives: Register for the free livestream.

To test whether TiFN’s weak social supervision could help to detect fake news effectively, the team validated it against a Politifact data set containing 120 true news pieces and 120 verifiably fake pieces shared among 23,865 users. Versus baseline detectors that consider only news content and some social interactions, the researchers report that TiFN achieved between 75% to 87% accuracy, even with a limited amount of weak social supervision (within 12 hours after the news was published).

In another experiment — involving a separate custom framework called Defend — the researchers sought to use news sentences and user comments explaining why a piece of news is fake as a weak supervision signal. Tested on a second Politifact data set consisting of 145 true news and 270 fake news pieces with 89,999 comments from 68,523 users on Twitter, they say Defend achieved 90% accuracy.

“[W]ith the help of weak social supervision from publisher-bias and user-credibility, the detection performance is better than those without utilizing weak social supervision. We [also] observe that when we eliminate [the] news content component, user comment component, or the co-attention for news contents and user comments, the performances are reduced. [This] indicates capturing the semantic relations between the weak social supervision from user comments and news contents is important,” wrote the researchers. “[W]e can see [that] within a certain range more weak social supervision leads to a larger performance increase, which shows the benefit of using weak social supervision.”

Source: https://venturebeat.com/2020/06/01/ai-tools-could-improve-fake-news-detection-by-analyzing-users-interactions-and-comments/

Datametrex $DM.ca Reports First Quarter Results

Posted by AGORACOM-JC at 8:42 AM on Wednesday, May 27th, 2020

Highlights for Q1 2020

  • The Company completed work for Democracy Labs on #disinformation in social media regarding #covid19 and #coronavirus and secured a relationship with Carnegie Mellon University IDeaS. These projects assisted in getting Nexalogy in front of the Government Agencies for the opportunity in the United States.
  • The Company continued the second phase of a multi-phase R&D program through the Department of National Defence’s Innovation for Defence Excellence and Security IDEaS program.  
  • The Company was chosen as preferred vendor partner by LOTTE Data Communication.

TORONTO, May 27, 2020 — Datametrex AI Limited (the “Company” or “Datametrex”) (TSXV: DM, FSE: D4G, OTC: DTMXF) is pleased to announce its financial results for Q1, ended March 31, 2020. 

Although certain projects and various sales negotiations have been postponed due to COVID-19 outbreaks, the Company was able to expand its businesses, and recorded increase in revenue for Q1 2020 by 62%, $809,402 compared to $498,565 in the previous year. Operating costs were reduced by 31% to $1,162,723 compared to $1,692,958 in the previous year. The net results  improved significantly with a decrease by 25%, ($721,761) compared to ($904,792) in the previous year. The Adjusted EBITDA also had a significant improvement with a decrease by 177%, ($257,303) compared to ($712,256). 

“In Q1 2020, we achieved multiple key milestones and made significant strides in strengthening our AI platform and offering, reducing operating costs, increasing sales, and focusing on our core business. This resulted in a substantial improvement to the bottom line,” says Marshall Gunter, CEO of the Company.

Highlights for Q1 2020

  • The Company completed work for Democracy Labs on #disinformation in social media regarding #covid19 and #coronavirus and secured a relationship with Carnegie Mellon University IDeaS. These projects assisted in getting Nexalogy in front of the Government Agencies for the opportunity in the United States.
  • The Company continued the second phase of a multi-phase R&D program through the Department of National Defence’s Innovation for Defence Excellence and Security IDEaS program.  
  • The Company was chosen as preferred vendor partner by LOTTE Data Communication.

Financial Highlights

The following table summarizes revenue, net loss and EBITDA* and Adjusted EBITDA* for the three months ended March 31, 2020 and 2019.

 For the three months ended 
 March 31, 2020 March 31, 2019 %
 $ $  
REVENUE  809,402   498,565 62%
NET LOSS  (721,761)  (904,792)25%
EBITDA  (528,303)  (723,529)37%
EBITDA per share  (0.002)  (0.003)68%
Adjusted EBTDA  (257,303)  (712,256)177%
Adjusted EBITDA per share  (0.001)  (0.003)34%

* Note: EBITDA (non-IFRS measures) is calculated as Net Loss ($721,761) adjusted for 1. Income taxes of ($16,207), 2. Depreciation and amortization of $194,899, and 3. Interest and accretion of $14,766. Adjusted EBITDA (non-IFRS measures) is calculated as EBITFA adjusted for share based compensation of 271,000.

Non-IFRS financial measures do not have standardized meaning prescribed by IFRS and are therefore unlikely to be comparable to similar measures presented by other companies. Specific items may only be relevant in certain periods. For reconciliation of non-IFRS financial measures please refer to the Company’s Management Discussion and Analysis for the three months ended March 31, 2020.

The financial statements, notes to the financial statements and Management’s Discussion and Analysis for the three months ended March 31, 2020 are available on the Company’s profile at SEDAR at www.sedar.com.

About Datametrex

Datametrex AI Limited is a technology focused company with exposure to Artificial Intelligence and Machine Learning through its wholly owned subsidiary, Nexalogy (www.nexalogy.com).

For further information, please contact:

Marshall Gunter – CEO
Phone: (514) 295-2300
Email: [email protected]

Jeff Stevens- Advisor
Phone: (647) 400-8494
Email: [email protected]

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws.  All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.

Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.